AC
ANGO icon

AXQ Capital’s AngioDynamics ANGO Stock Holding History

AXQ Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,231
Closed -$270K – 574
2025
Q2 		$270K Buy
27,231
+7,011
+35% +$68.6K 0.09% 394
2025
Q1 		$190K Buy
+20,220
New +$212K 0.08% 403
2024
Q3 		– Sell
-17,272
Closed -$104K – 425
2024
Q2 		$104K Buy
17,272
+3
+0% +$19 0.02% 417
2024
Q1 		$101K Buy
+17,269
New +$103K 0.02% 574

Other funds holding ANGO

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AXQ Capital's ANGO Position: Q3 2025 in Review

AXQ Capital sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 27,231 shares — an estimated $270K sold.

AXQ Capital first reported a position in ANGO in Q1 2024 and held it in 4 quarters. The position peaked at $270K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • AXQ Capital reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • AXQ Capital sold 27,231 AngioDynamics shares in Q3 2025, an estimated $270K.
  • AXQ Capital first reported a position in AngioDynamics in Q1 2024 and held it in 4 quarters.
  • AXQ Capital's AngioDynamics position peaked at $270K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.